Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Heuvel, M.M. van den
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(13)
+
-
Availability
Open access
(9)
+
-
Metadata Only
(5)
+
-
Creation Date
2021
(4)
+
-
2022
(4)
+
-
2019
(2)
+
-
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(11)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(11)
+
-
Scholarly Publications
(3)
+
-
Topic
non-small cell lung cancer
(2)
+
-
Author
Heuvel, M.M. van den
(14)
+
-
Muller, M.
(6)
+
-
Smit, E.F.
(6)
+
-
Noort, V. van der
(4)
+
-
Steeghs, N.
(4)
+
-
Baas, P.
(3)
+
-
Broek, D. van den
(3)
+
-
Huitema, A.D.R.
(3)
+
-
Langen, A.J. de
(3)
+
-
Monkhorst, K.
(3)
+
-
Bahce, I.
(2)
+
-
Beijnen, J.H.
(2)
+
-
Buma, A.I.G.
(2)
+
-
Croes, S.
(2)
+
-
Dingemans, A.M.C.
(2)
+
-
Duijl, T.T. van
(2)
+
-
Farzan, N.
(2)
+
-
Hartemink, K.J.
(2)
+
-
Hashemi, S.M.S.
(2)
+
-
Heine, R. ter
(2)
+
-
Hendriks, L.E.L.
(2)
+
-
Janssen, J.M.
(2)
+
-
Kremer, L.C.M.
(2)
+
-
Loonen, J.
(2)
+
-
Louwerens, M.
(2)
+
-
Pal, H.J.H. van der
(2)
+
-
Schouten, R.D.
(2)
+
-
Schuuring, E.
(2)
+
-
Sterk, P.J.
(2)
+
-
Timens, W.
(2)
+
-
Tissing, W.J.E.
(2)
+
-
Verheijen, R.B.
(2)
+
-
Vries, A.C.H. de
(2)
+
-
Vries, R. de
(2)
+
-
Wekken, A.J. van der
(2)
+
-
Wolf-Lansdorf, M.
(2)
+
-
Show more
Language
en
(14)
+
-
Search results
(1 - 14 of 14)
show grid
show list
save search
A systematic evaluation of cost-saving dosing regimens for therapeutic antibodies and antibody-drug conjugates for the treatment of lung cancer
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients
PD-1T TILs as a predictive biomarker for clinical benefit to PD-1 blockade in patients with advanced NSCLC
Detection and localization of early- and late-stage cancers using platelet RNA
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR-mutant non-small cell lung cancer
The Impact of Cancer-Related Fatigue on HRQOL in Survivors of Childhood Cancer: A DCCSS LATER Study
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer (vol 160, pg 36, 2021)
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
Nivolumab in pre-treated advanced non-small cell lung cancer
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review
Germline Mitochondrial DNA Mutations As a Novel First Event in Childhood Myelodysplastic Syndrome